94386 ⎘
Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems Benzopyrazoles; Hydrogenated benzopyrazoles
PPAR active compounds
#1202SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF
#1203Benzene, Pyridine, and Pyridazine Derivatives
#1204Heterocyclic carbonyl compounds
#1205Retinoid x receptor modulators
#1206Indazole compounds as B3 adrenoceptor agonist
#1207Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
#1208Crystal forms of substituted phenylalkanoic acids and process for producing the same
#1209Purine, Pyrimidine, and Azaindole Derivatives
#1210Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#1211Thiourea derivatives and the pharmaceutical compositions containing the same
#12121-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
#1213Chemical Compounds
#1214Compounds that inhibit TRPV1 and uses thereof
#1215Tetrahydro-2H-indazole pyrazole cannabinoid modulators
#1216PPAR active compounds
#1217Compounds which potentiate AMPA receptor and uses thereof in medicine
#1218Non-nucleoside reverse transcriptase inhibitors
#1219INTERMEDIATES AND METHODS FOR SEROTONERGIC AGONIST SYNTHESIS
#1220PROCESS FOR PREPARING PYRANOINDAZOLE SEROTONERGIC RECEPTOR AGONISTS
#1221Substituted Fused Pyrroleoximes and Fused Pyrazoleoximes
#1222Ophthalmic compositions for treating ocular hypertension
#12231-Acetic Acid-Indole, -Indazole and -Benzimidazole Derivatives Useful for the Treatment of Respiratory Disorders
#12241-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
#1225Inhibitors of hepatitis C virus replication
#1226Indazole compounds as β3 andrenoceptor agonist
#1227Hydroxamates as therapeutic agents
#1228Anti-Cancer Agents
#1229Indazole Sulphonamide Derivatives
#1230Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
#1231Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors
#1232Anticancer compositions, and methods of making and using the same
#1233NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS
#1234Anticancer compositions, and methods of making and using the same
#1235Chemical compounds
#1236Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
#12371-Sulfonylindazolylamine and - amide derivatives as 5-hydroxytryptamine-6 ligands
#1238Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
#1239Pyrimidineamines as angiogenesis modulators
#1240Compounds
#1241Nitro Indazole Derivatives
#1242Substituted bis aryl and heteroaryl compounds as selective 5HTantagonists
#1243Novel Compounds
#1244Phosphodiesterase 4 inhibitors
#1245Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptors
#1246GLUCOKINASE ACTIVATORS
#1247Sulfonylamino-acetic acid derivatives
#1248N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES
#1249(4, 5, 6, 7-tetrahydro-1-H-indol-7-yl) acetic acid derivatives for treatment of Alzheimer's disease
#12503-aminoindazoles
#1251Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
#1252Substituted pyrazole sigma receptor antagonists
#1253Substituted 4-(Indazol-3-yl)phenols
#1254Tetrahydronaphthalene derivatives, methods for the production thereof, and the use thereof as antiphlogistics
#1255Viral polymerase inhibitors
#1256Indazole derivatives as CRF antagonists
#1257Cyclohexylamino Benzene, Pyridine, and Pyridazine Derivatives
#1258Phosphodiesterase 4 inhibitors
#1259METHODS OF PREPARING INDAZOLE COMPOUNDS
#1260Pyrazoles for the treatment of obesity and other CNS disorders
#1261Novel compounds that are ERK inhibitors
#1262Novel piperidine derivative for the treatment of depression
#1263Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
#1264Multicore indazolinone library
#1265Cyclic compounds
#1266Urea derivatives, processes for their preparation, their use as medicaments, and pharmaceutical compositions containing them
#1267Indazole compound and pharmaceutical use thereof
#1268Method for the production of tetrahydrogeranylacetone
#1269Therapeutic amide derivatives
#1270Benzamide derivative or salt thereof
#1271Substituted indazoles, compositions containing the same, and the preparation and use thereof
#1272PPAR active compounds
#1273Hsp90 family protein inhibitors
#1274Meta-benzamidine derivatives as serine protease inhibitors
#1275Antiinflammation agents
#1276Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
#1277Substituted Heterocyclic Compounds
#1278PPAR active compounds
#1279Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
#1280N-linked aryl heteroaryl inhibitors of LTA4H for treating inflammation
#1281Calcium receptor modulating agents
#1282N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
#1283Ophthalmic compositions for treating ocular hypertension
#1284Indazole derivatives
#1285Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof
#1286Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1)
#1287Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
#12883-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof
#1289Substituted 3-amido-tetrahydro-indazolyl cannabinoid modulators
#1290Indazole derivatives
#1291Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
#1292Opioid receptor antagonists
#1293Bicyclic derivatives as PPAR modulators
#12942-or 3-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
#1295Alkynyl aryl carboxamides
#1296Prodrugs of compounds that inhibit TRPV1 receptor
#1297Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
#1298CB1 antagonist compounds
#1299Acyclic Iinhibitors
#1300Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain
#1301Apoptosis promoters
#1302Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitors
#13034-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors
#1304Monocyclic and bicyclic compounds and methods of use
#1305Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
#1306Methods for treating, preventing and managing chronic lymphocytic leukemia with indazole compounds
#1307Substituted pyrazolo[3,4-d]pyrimidines as p38 MAP kinase inhibitors
#1308Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
#1309p38 MAP kinase inhibitors and methods for using the same
#1310Pyrazolones as 11b-HSD1 inhibitors for diabetes
#1311Lonidamine analogs
#1312N-alkyny-2-(substituted aryloxy) alkylthioamine derivatives as fungicides
#1313Inhibitors of P2X
#1314Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
#1315Pyrazole derivatives and use thereof as orexin receptor antagonists
#1316HIV reverse transcriptase inhibitors
#1317NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF
#1318Histone deacetylase inhibitors
#1319Apoptosis promoters
#1320Lonidamine analogs
#1321NPY Y5 antagonist
#1322Pyrimidineamines as angiogenesis modulators
#1323Indazole having analgesic activity
#1324Protein kinase inhibitors
#1325Substituted aryloxymethyl bicyclicmethyl acetamide compounds
#1326Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds
#1327P38 inhibitors and methods of use thereof
#1328Substituted Heteroaryl- and Phenylsulfamoyl Compounds
#1329Chemical process
#1330Benzocycloheptene derivatives, process for their production and their use as anti-inflammatory agents
#1331Hydroxysteroid dehydrogenase inhibitors
#1332Processes for producing pyrazoloacridone derivative and synthetic intermediate thereof
#1333Therapeutic pyrazolo[3,4-b]pyridines and indazoles
#13343-oxo-1, 3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors
#1335Benzene, pyridine, and pyridazine derivatives
#1336Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
#1337Factor Xa compounds
#1338Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
#1339Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
#1340Substituted biaryl amides C5a receptor modulators
#1341Heterocyclic-substituted phenyl methanones
#1342Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
#1343Combretastatin derivatives with cytotoxic action
#1344Phosphodiesterase 4 inhibitors
#1345Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
#1346Substituted biaryl compounds as factor XIa inhibitors
#1347Ophthalmic compositions for treating ocular hypertension
#1348Anti-tumor compounds
#1349Heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A
#13501h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitors
#1351Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
#1352Cyclic derivatives as modulators of chemokine receptors activity
#1353Oxime derivative hydroxyethylamine aspartyl-protease inhibitors
#1354Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors
#1355Processes for the preparation of CGRP-receptor antagonists and intermediates thereof
#1356Fused heteroaryl derivatives for use as P38 kinase inhibitors
#13571-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
#1358Therapeutic pyrazolo[3,4-b]pyridines and indazoles
#1359Preparation and purification of 4-(indazol-3-yl)phenols
#1360Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
#1361Substituted piperazines
#1362[(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones
#1363Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
#1364Synthesis of -(substituted arylmethyl)-3-(substituted phenyl)indazoles as novel anti-angiogenic agents
#1365Methods of preparing indazole compounds
#1366Heterocyclic aromatic compounds useful as growth hormone secretagogues
#1367Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
#1368Indazolone derivatives useful as 11b-HSD1 inhibitors
#1369Aryl ureido benzoic acid derivatives and their use
#1370Heterocyclic aromatic compounds useful as growth hormone secretagogues
#1371Jnk inhibitor
#13721-alkyl-3-aminoindazoles
#1373Sigma receptor inhibitors
#1374Lonidamine analogues and their use in male contraception and cancer treatment
#1375Guanidine mimics as factor Xa inhibitors
#1376Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
#1377Vanilloid receptor ligands and their use in treatments
#1378Indazoles
#13793-amino-1-arylpropyl indoles as monoamine reuptake inhibitors
#1380Indazole-aminoacetonitrile derivatives having special pesticidal activity
#1381Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#1382Ophthalmic compositions for treating ocular hypertension
#1383Sulfonylamino-acetic acid derivatives
#1384Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors
#1385PPAR active compounds
#13861H-indazole compounds
#1387Vanilloid receptor ligands and their use in treatments
#1388Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
#1389Vanilloid receptor ligands and their use in treatments
#1390Vanilloid receptor ligands and their use in treatments
#1391Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#1392Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents
#1393Vanilloid receptor ligands and their use in treatments
#1394Vanilloid receptor ligands and their use in treatments
#1395Modulators of cellular adhesion
#1396Pyrazole compound and medicinal composition containing the same
#1397Preparation of phosphatase inhibitors
#1398Substituted piperazines
#1399Heterocyclic inhibitors of MEK and methods of use thereof
#1400Heterocyclic inhibitors of MEK and methods of use thereof
#1401Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
#1402Tetrahydro-indazole cannabinoid modulators
#1403Substituted heteroaryl- and phenylsulfamoyl compounds
#1404Bicyclic heterocycles useful as serine protease inhibitors
#140511β-hydroxysteroid dehydrogenase inhibitors
#1406Vanilloid receptor ligands and their use in treatments
#1407Fluorescent dyes (AIDA) for solid phase and solution phase screening
#1408Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
#1409Fused pyrazolyl compound
#1410Indazole derivatives and methods for using the same
#1411Serine protease inhibitors
#1412Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#1413Pyrazole compounds and pharmaceutical compositions comprising the compound
#1414Indazole derivatives as inhibitors of hormone sensitive lipase
#1415Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
#1416Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
#1417Compound for treating angiogenesis
#1418Hydroxamates as therapeutic agents
#1419Methods of treating sepsis
#1420Hetero-substituted acetanilide derivatives as analgesic agents
#1421Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
#1422Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism
#1423Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#1424Process for asymmetric intramolecular [3+2] cyclo-addition of hydrazones
#1425Urea derivatives
#1426Substituted aryl amides
#1427N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
#1428Heterocyclic inhibitors of MEK and methods of use thereof
#1429Modulators of ATP-binding cassette transporters
#1430Insecticidal amides with nitrogen-containing benzo-Fused bicyclic ring systems
#1431Pyrrole and pyrazole DAAO inhibitors
#1432Calcium receptor modulating agents
#1433Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
#1434Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
#1435Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
#1436Bicyclic inhibitors of MEK and methods of use thereof
#1437AKT protein kinase inhibitors
#1438Bicyclic inhibitors of MEK and methods of use thereof
#1439Immobilized N-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
#1440Benzylcycloalkyl amines as modulators of chemokine receptor activity
#1441Urea derivatives
#1442Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
#1443Antibacterial agents
#1444Therapeutic substituted indazole derivatives
#1445Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
#1446Heterocyclic GABAA subtype selective receptor modulators
#1447Substituted biaryl amides as C5A receptor modulators
#1448Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
#1449Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
#1450Substituted fused pyrroleoximes and fused pyrazoleoximes
#1451Substituted indazoles, compositions containing them, method of production and use
#1452Compositions and methods for the treatment of disease associated with Trp-p8 expression
#1453Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
#1454Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
#1455Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
#1456Piperazine derivatives
#1457PPAR active compounds
#1458Compositions containing a ruthenium(III) complex and a heterocycle
#1459Compounds
#1460Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
#1461Indazole compounds as β3 adrenoceptor agonist
#1462Aryl-heteroaromatic compounds, compositions comprising them and use
#1463Drugs comprising combination of antithrombotic agent with pyrazolone derivative
#1464Indazole compounds, compositions thereof and methods of treatment therewith
#1465Ubiquitin ligase inhibitors
#14661-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
#1467Modulators of VR1 receptor
#1468Synthesis of thiosemicarbazide analogue as inhibitor of tyrosinase, skin hyperpigmentation, and fruit and/or vegetable browning
#1469Cathepsin L inhibitors
#1470Kinase inhibitors